Tim-3/galectin-9调控脂多糖诱导的人淋巴细胞中Th1/Th2细胞平衡

doi:10.16352/j.issn.1001-6325.2023.10.1542

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (10): 1542-1548.doi: 10.16352/j.issn.1001-6325.2023.10.1542

Tim-3/galectin-9调控脂多糖诱导的人淋巴细胞中Th1/Th2细胞平衡

孙晓丽¹, 张进进¹, 宋凤英², 黄永莉¹, 陈立力¹, 邢颜超^1*

1.新疆军区总医院输血科,新疆乌鲁木齐 830000;
2.新疆维吾尔自治区塔城地区裕民县人民医院检验科,新疆裕民 834700

收稿日期:2023-03-13 修回日期:2023-07-24 出版日期:2023-10-05 发布日期:2023-10-05
通讯作者: *xingyanchao@aliyun.com
基金资助:
新疆维吾尔自治区自然科学基金青年科学基金(2022D01C843)

Tim-3/galectin-9 regulates Th1/Th2 cell balance in lipopolysaccharide-induced human lymphocytes

SUN Xiaoli¹, ZHANG Jinjin¹, SONG Fengying², HUANG Yongli¹, CHEN Lili¹, XING Yanchao^1*

1. Department of Blood Transfusion, General Hospital of Xinjiang Military Command, Urumqi 830000;
2. Department of Clinical Laboratory, Yumin County People's Hospital, Yumin 834700,China

Received:2023-03-13 Revised:2023-07-24 Online:2023-10-05 Published:2023-10-05
Contact: *xingyanchao@aliyun.com

摘要/Abstract

摘要： 目的探讨T细胞免疫球蛋白黏蛋白分子-3(Tim-3)/半乳糖凝集素-9(galectin-9)在脂多糖(LPS)诱导淋巴细胞炎性过程中对辅助性T细胞(Th)Th1/Th2细胞失衡中的作用。方法收集脓毒症患者的外周血。分离外周血单个核细胞(PBMC),RT-qPCR检测Tim-3、galectin-9、T-bet和GATA3的表达;ELISA检测血清sTim-3、galectin-9、IFN-γ和IL-4的水平;分离的外周血单个核细胞体外培养,LPS刺激建立体外炎性模型;ELISA法检测细胞培养上清中Th1和Th2细胞相关细胞因子的水平;Western blot检测JAK2/STAT3相关因子的表达;Pearson相关系数分析Tim-3、galectin-9、IFN-γ和IL-4的相关性。结果脓毒症患者外周血中Tim-3和galectin-9的mRNA表达增多,sTim-3、galectin-9、IL-4和GATA-3升高,IFN-γ和T-bet水平下降,磷酸化JAK2和STAT3升高(P＜0.05)。阻断Tim-3表达后,IFN-γ水平升高,而IL-4的水平明显下降,磷酸化JAK2和STAT3下降(P＜0.05)。Tim-3、IL-4与galectin-9呈正相关,而Tim-3与IFN-γ呈负相关,IFN-γ与galectin-9呈负相关,Tim-3与IL-4呈正相关。结论在LPS诱导的炎性细胞中,Tim-3/galectin-9可能调控JAK2/STAT3通路,导致Th1/Th2细胞的失衡。

关键词: T细胞免疫球蛋白黏蛋白分子-3, 半乳糖凝集素-9, 辅助性T细胞, JAK2/STAT3通路, 脓毒症

Abstract: Objective To investigate the mechanism of Tim-3/galectin-9 in T helper type 1/2 (Th1/Th2) cell imbalance in lipopolysaccharide(LPS)-induced human lymphocytes. Methods Peripheral blood mononuclear cells (PBMC) were isolated from patients with sepsis. The expression of Tim-3, galectin-9, T-bet and GATA3 were detected by RT-qPCR; ELISA was used for detecting sTim-3, galectin-9, IFN-γ and IL-4.Isolated peripheral blood mononuclear cells were incubated with LPS and then cytokines related to Th1 and Th2 cells in the supernatant of cell culture were detected by ELISA; Western blot was used to detect the expression of JAK2/STAT3 related factors; Pearson correlation coefficient analysis was performed to identify relationship among Tim-3, galectin-9,IFN-γ and IL-4. Results The mRNA expression of Tim-3 and galectin-9 in peripheral blood of patients with sepsis was increased, and protein expression of Tim-3, galectin-9, IL-4 and GATA-3 was increased significantly. The levels of IFN-γ and T-bet were decreased and levels of p-JAK2 and p-STAT3 were elevated. After blocking Tim-3 expression, IFN-γ level increased, while IL-4 level decreased significantly. Phosphorylation of JAK2 and STAT3 decreased. Level of Tim-3 and of IL-4 was positively correlated with galectin-9, while Tim-3 was negatively correlated with IFN-γ;IFN-γ was negatively correlated with galectin-9, and Tim-3 was positively correlated with IL-4. Conclusions Tim-3/galectin-9 regulates the JAK2/STAT3 pathway and leads to the imbalance of Th1/Th2 cells in LPS induced inflammation.

Key words: Tim-3, galectin-9, T helper cells, JAK2/STAT3 pathway, sepsis

孙晓丽, 张进进, 宋凤英, 黄永莉, 陈立力, 邢颜超. Tim-3/galectin-9调控脂多糖诱导的人淋巴细胞中Th1/Th2细胞平衡[J]. 基础医学与临床, 2023, 43(10): 1542-1548.

SUN Xiaoli, ZHANG Jinjin, SONG Fengying, HUANG Yongli, CHEN Lili, XING Yanchao. Tim-3/galectin-9 regulates Th1/Th2 cell balance in lipopolysaccharide-induced human lymphocytes[J]. Basic & Clinical Medicine, 2023, 43(10): 1542-1548.

参考文献 15

[1]	Delano MJ, Ward PA. Sepsis-induced immune dysfunc-tion: Can immune therapies reduce mortality[J]. J Clin Invest, 2016,126:23-31.
[2]	Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases[J]. Cytokine, 2015,74:5-17.
[3]	Gupta DL, Bhoi S, Mohan T, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis[J]. Cytokine, 2016,88:214-221.
[4]	Joller N, Kuchroo VK. Tim-3, Lag-3, and TIGIT[J]. Curr Top Microbiol Immunol, 2017, 10:127-156.
[5]	Johannes L, Jacob R, Leffler H. Galectins at a glance[J]. J Cell Sci, 2018,131-140.
[6]	Ungerer C, Quade-Lyssy P, Radeke HH, et al. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations[J]. Stem Cells Dev, 2014,23:755-766.
[7]	Emira B, Hamidreza MA. “Do we know Jack” about JAK? A closer look at JAK/STAT signaling pathway[J]. Front Oncol, 2018, 31;287-307.
[8]	Bernd G, Viktoria M. Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition[J]. Mol Cell Endocrinol, 2017,451:1-14.
[9]	Charles JM. The role of the JAK/STAT signal pathway in rheumatoid arthritis[J]. Ther Adv Musculoskelet Dis, 2018, 10:117-127
[10]	Bu M, Shen Y, Seeger WL, et al. Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression[J]. Tumour Biol, 2016,37:3949-3956.
[11]	Madireddi S, Eun SY, Lee SW, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies[J]. J Exp Med, 2014,211:1433-1448.
[12]	曾放, 刘顺, 孙科明, 等. Tim-3/Gal-9通路在免疫相关疾病中的研究进展[J]. 医学综述, 2016, 22:1044-1047
[13]	Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion[J]. Nat Rev Immunol, 2015, 15:486-499.
[14]	Cho JL, Roche MI, Sandall B, et al. Enhanced Tim3 activity improves survival after influenza infection[J]. J Immunol, 2012,189:2879-2889.
[15]	Moodley YP, Misso NL, Scaffidi AK. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs[J]. Am J Respir Cell Mol Biol, 2003, 29:490-498.

Tim-3/galectin-9调控脂多糖诱导的人淋巴细胞中Th1/Th2细胞平衡

Tim-3/galectin-9 regulates Th1/Th2 cell balance in lipopolysaccharide-induced human lymphocytes

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 15

相关文章 15

编辑推荐

Metrics

本文评价

[1]	袁策, 叶萃萃, 郭长安, 罗来升, 柳月珍. 中性粒细胞胞外诱捕网在脓毒症相关急性肺损伤中的作用[J]. 基础医学与临床, 2026, 46(4): 597-601.
[2]	陶宁宁, 王海超, 苏月琴. 连续性肾脏替代治疗联合血液灌流对脓毒症急性肾损伤患者的疗效[J]. 基础医学与临床, 2026, 46(2): 267-272.
[3]	刘婷婷, 郜玲, 李筱妍. 中性粒细胞胞外诱捕网在脓毒症诱导的急性呼吸窘迫综合征中的研究进展[J]. 基础医学与临床, 2026, 46(1): 139-143.
[4]	牛昕妤, 孙志明, 谢旻, 李双玲. 干细胞治疗脓毒症的临床研究进展[J]. 基础医学与临床, 2025, 45(9): 1234-1238.
[5]	刘宇涵, 王莹莹, 王钰铖, 郭磊, 鞠瑞. 敲除Mcart1加重脓毒症模型小鼠巨噬细胞炎性反应水平[J]. 基础医学与临床, 2025, 45(5): 616-621.
[6]	王婷婷, 秦海东. 脓毒症相关细胞因子风暴的机制与治疗策略[J]. 基础医学与临床, 2025, 45(2): 263-267.
[7]	吴定将, 张秀峰. MBD2通路在重症哮喘中作用的研究进展[J]. 基础医学与临床, 2024, 44(8): 1165-1169.
[8]	刘怡斐, 王鑫宇, 王嘉慧, 杜晓冰, 王途, 赵娟. 尾加压素Ⅱ受体拮抗剂(urantide)减轻动脉粥样硬化大鼠肾脏损伤[J]. 基础医学与临床, 2023, 43(11): 1668-1672.
[9]	王英臣, 孙立群. 二肽基肽酶Ⅲ在治疗脓毒症中的应用进展[J]. 基础医学与临床, 2023, 43(1): 196-199.
[10]	薛晋芳, 宋海飞, 陈国兵. 程序性细胞死亡在脓毒症发生发展中的研究进展[J]. 基础医学与临床, 2022, 42(8): 1284-1287.
[11]	匡重伸, 丛竹凯, 吴长毅, 杨宁, 宗亚楠, 郭向阳. 内脂素在脓毒症相关性脏器损伤中的作用及机制研究进展[J]. 基础医学与临床, 2022, 42(8): 1279-1283.
[12]	林柏柏, 钱风华, 钱义明, 赵雷, 孙旗, 褚梦瑶, 沈梦雯. 脓毒症并发毛细血管渗漏综合征的研究进展[J]. 基础医学与临床, 2022, 42(7): 1144-1147.
[13]	温燕, 林金灿, 黄颖泓, 肖文彪, 张民伟, 林建东. 脓毒症早期BMP-2和BMP-4的变化[J]. 基础医学与临床, 2022, 42(4): 628-632.
[14]	石丹丹, 蒋素芳, 王茜, 赵鹏博, 刘雅. IL-6反式信号传导通路抑制剂sgp130Fc抑制脓毒症小鼠炎性反应及调节免疫细胞[J]. 基础医学与临床, 2022, 42(12): 1895-1899.
[15]	李嘉晋, 刘军, 何松于, 谌浩云. 下调miR-27a减轻脓毒症模型大鼠肺损伤[J]. 基础医学与临床, 2022, 42(11): 1704-1708.